Curoverse, Inc. — Form D
Curoverse, Inc. of BOSTON, MA, a company, filed a Form D exempt-offering notice with the SEC on 2015-03-25. The offering totals $2.0M, of which $500K was reported sold. Industry: Other.
Offering
- Filed: 2015-03-25
- Form: D
- Accession: 0001586571-15-000001
- Industry: Other
- Exemptions: 06b
- Total offering: $2.0M
- Amount sold: $500K
- Remaining: $1.5M
- Investors: 3
- Date of first sale: 2015-03-09
- Security types: debt
- Revenue range: Decline to Disclose
- SEC file number: 021-236561
Issuer
- Name: Curoverse, Inc.
- CIK: 0001586571
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2010
- Address: 332 CONGRESS STREET, BOSTON, MA, 02210
- Phone: 617-937-2300
Officers, directors & promoters (8)
| Name | Role | Location |
|---|
| Jeremy Allaire | Director | New York, NY |
| Adam Berrey | Director | Boston, MA |
| David Martirano | Director | Boston, MA |
| Clay Throp | Director | Boston, MA |
| Alexander Wait Zaranek | Director | Boston, MA |
| Adam Berrey | Executive Officer | Boston, MA |
| Ward Vandewege | Executive Officer | Boston, MA |
| Michael Dial | Director | Durham, NC |
Other filings by this issuer (2)
More